Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery

Surgery for Obesity and Related Diseases

Volumn 7, Issue 2, 2011, Pages 195-198

  De Luis, Daniel Antonio ^a   Izaola, Olatz ^a   Conde, Rosa ^a   Primo, David ^a   Sagrado, Manuel Gonzlez ^a   Aller, Rocio ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Biliopancreatic diversion; Females; Morbid obesity; Surgery; Visfatin

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ANTHROPOMETRY; ARTICLE; BILIOPANCREATIC DIVERSION SURGERY; BLOOD PRESSURE; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MORBID OBESITY; PANCREAS SURGERY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

BILIOPANCREATIC DIVERSION; BIOLOGICAL MARKERS; BODY MASS INDEX; DIABETES MELLITUS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRA-ABDOMINAL FAT; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY, MORBID; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 79952991557     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2010.08.008     Document Type: Article

References (21)

1. G. Fantuzzi Adipose tissue, adipokines, and inflammation J Allergy Clin Immunol 115 2005 911 919
2. A. Fukuhara, M. Matsuda, and M. Nishizawa Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 (Pubitemid 40139988)
3. S. Ognjanovic Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes J Mol Endocrinol 26 2001 107 117 (Pubitemid 32266186)
4. D.A. de Luis, R. Aller, O. Izaola, R. Conde, M. Gonzalez, and E. Romero Effect of a hypocaloric diet on circulating visfatin in obese non diabetic patients Nutrition 24 2008 517 521
5. J.I. Botella, M. Luque, F. Alvarez Blasco, R. Peromingo, J.L. San Millan, and H.F. Escobar Morreale The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference and presence or absence of diabetes mellitus Obes Surg 18 2008 1000 1006
6. K. Krzyzanowska, F. Mittermayer, W. Krugluger, H.P. Kopp, and G. Schernthaner Increase in visfatin after weight loss induced by gastroplastic surgery Obesity (Silver Spring) 14 2006 1886 1889 (Pubitemid 46121917)
7. M. Manco, J.M. Fernandez-Real, and F. Equitani Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women J Clin Endocrinol Metab 92 2007 483 490
8. D.A. de Luis, R. Aller, O. Izaola, and D. Pacheco Early clinical and surgical results of biliopancreatic diversion Obes Surg 15 2005 799 802 (Pubitemid 40904869)
9. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2487
10. American Diabetes Association Standards of diabetes mellitus Diabetes Care 30 2007 s4 s41
11. D.G. Haider, K. Schindler, G. Schaller, G. Prager, M. Wolzt, and B. Ludvik Increased plasma visfatin concentrations in morbidly obese Obes Surg 18 2008 1000 1006
12. N. Kloting, and I. Kloting Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOWK rats compared with lean control rats Biochem Biophys Res Commun 332 2005 1070 1072 (Pubitemid 40798194)
13. E. Garcia Fuentes, J.M. Garcia Almeida, J. Garcia Arnes, S. Garcia Serrano, J. Rivas Marin, and J. Galego Perales Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass Obes Surg 15 2007 2391 2395
14. D.G. Haider, K. Schindles, G. Schaller, G. Prager, M. Woltz, and B. Ludvik Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding J Clin Endocrinol Metab 91 2006 1578 1581
15. K. Krzyzanowska, F. Mitternmayer, W. Krugluger, H.O. Kopp, and G. Schernthaner Increase in visfatin after weight loss induced by gastroplastic surgery Obesity 14 2006 1886 1889 (Pubitemid 46121917)
16. M. Kovacikova, M. Vitkova, E. Klimcakova, J. Polak, J. Hejnova, and M. Bajzova Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction Eur J Clin Invest 38 2008 516 522 (Pubitemid 351832035)
17. L. Li, G. Yang, Q. Li, Y. Tang, M. Yahg, and H. Yang Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects Exp Clin Endocrinol Diabetes 114 2006 544 548 (Pubitemid 46087259)
18. T. Dogru, A. Sonmez, I. Tasci, E. Bozoglu, M.I. Yilmaz, and H. Genc Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance Diabetes Res Clin Pract 76 2007 24 29 (Pubitemid 46240362)
19. D.G. Haider, G. Schaller, S. Kapiotis, C. Maier, A. Luger, and M. Woltz The release of the adipocytokine visfatin is regulated by glucose and insulin Diabetologia 49 2006 1909 1914 (Pubitemid 44025046)
20. J.H. Kim, S.H. Kim, J.A. Im, and D.C. Lee The relationship between visfatin and metabolic syndrome in postmenopausal women Maturitas Epub 2010 May 25
21. V. Cataln, J. Gmez-Ambrosi, and A. Rodrguez Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity Nutr Metab Cardiovasc Dis Epub 2010 Jan 25